Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
25 Feb 2025 |
About Corporate Governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
07 Feb 2025 |
On P&L |
The Company informs on some of the results expected by the market consensus
|
Download |
|
07 Nov 2024 |
On P&L |
The Company releases the press release related to the first nine months 2024 financial results
|
Download |
|
07 Nov 2024 |
On P&L |
The Company releases the first nine months 2024 financial results presentation
|
Download |
|
24 Oct 2024 |
On corporate transactions |
ROVI completes the strategic review of its CDMO business
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
25 Feb 2025 |
Annual Report regarding remuneration of the members of the Board of Directors |
ROVI releases the 2024 annual report regarding remuneration of the members of the Board of Directors
|
Download |
|
07 Jan 2025 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the fourth quarter of 2024
|
Download |
|
07 Nov 2024 |
On P&L |
A correction to the English version of a document is reported.
|
Download |
|
03 Oct 2024 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the third quarter of 2024
|
Download |
|
12 Sep 2024 |
Other relevant information |
The Company announces the registration in the Commercial Registry of the public deed of reduction of its share capital and the new share capital figure.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
08 Jan 2018 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the fourth quarter of 2017
|
Download |
|
21 Dec 2017 |
Préstamos, créditos y avales |
ROVI and the EIB agree to sign a loan to boost research into drug administration and prolonged-release technologies
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the press release related to the nine-month period ended 30 September 2017 results
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the presentation related to the nine-month period ended 30 September 2017 results.
|
Download |
|
24 Oct 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® project.
|
Download |
Pages
